Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axion BioSystems is a leading life science tools company that provides advanced live-cell analysis systems for researchers in drug discovery and disease modeling. The company's core technology includes the Maestro multi-electrode array (MEA) platform, which allows for the non-invasive, label-free monitoring of cellular activity in real-time. Following recent strategic acquisitions, Axion has expanded its portfolio to include high-throughput single-cell sorting and live-cell imaging solutions. Their products are widely used in the development of cell and gene therapies, as well as in toxicology and neuroscience research. Axion BioSystems is headquartered in Atlanta, Georgia, and serves a global customer base across academia and the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axion Spatial Imaging.